ORIGINAL CONTRIBUTION. Hepatocerebral Form of Mitochondrial DNA Depletion Syndrome
|
|
- Erin Stone
- 5 years ago
- Views:
Transcription
1 ORIGINAL CONTRIBUTION Hepatocerebral Form of Mitochondrial DNA Depletion Syndrome Novel MPV17 Mutations Antonella Spinazzola, MD; René Santer, MD; Orhan H. Akman, PhD; Kostas Tsiakas, MD; Hansjoerg Schaefer, MD; Xiaoqi Ding, MD; Charalampos L. Karadimas, MD; Sara Shanske, PhD; Jaya Ganesh, MD; Salvatore Di Mauro, MD; Massimo Zeviani, MD, PhD Background: Autosomal recessive mutations in MPV17 (OMIM *137960) have been identified in the hepatocerebral form of mitochondrial DNA depletion syndrome (MDS). Objective: To describe the clinical, morphologic, and genetic findings in 3 children with MPV17-related MDS from 2 unrelated families. Design: Case report. Setting: Academic research. Main Outcome Measures: We identified 3 novel pathogenic mutations in 3 children. Results: Two children were homozygous for nonsense mutation p.w120x. A third child was compound heterozygous for missense mutation p.g24w and for a macrodeletion spanning MPV17 exon 8. All patients demonstrated lactic acidosis, hypoglycemia, hepatomegaly, and progressive liver failure. Neurologic symptoms manifested at a later stage of the disease. Death occurred within the first year of life in all 3 patients. Conclusions: These data confirm that MPV17 mutations are associated with a 2-stage syndrome. The first symptoms are metabolic and rapidly progress to hepatic failure. This stage is followed by neurologic involvement affecting the central and peripheral systems. Arch Neurol. 2008;65(8): Author Affiliations: Unit of Molecular Neurogenetics, Pierfranco and Luisa Mariani Center for the Study of Children s Mitochondrial Disorders, C. Besta Neurological Institute Foundation, Milan, Italy (Drs Spinazzola and Zeviani); Departments of Pediatrics (Drs Santer and Tsiakas), Pathology (Dr Schaefer), and Neuroradiology (Dr Ding), University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, Columbia University Medical Center, New York, New York (Drs Akman, Karadimas, Shanske, and Di Mauro); and Department of Metabolism and Genetics, University of Pennsylvania School of Medicine, Children s Hospital of Philadelphia, Philadelphia, Pennsylvania (Dr Ganesh). MITOCHONDRIAL DNA depletion syndrome (MDS) is characterized by a quantitative abnormality of the mitochondrial genome inherited as an autosomal recessive trait. Although decreased in amount, residual mitochondrial DNA (mtdna) does not harbor any mutations or rearrangements. Because the primary abnormality resides in a nuclear gene but the target DNA is mitochondrial, MDS is an example of a group of mitochondrial disorders labeled as defects of intergenomic communication. Some individuals with MDS have muscle weakness, others demonstrate liver failure, and still others manifest multisystem involvement and lactic acidosis. Consistent with different phenotypes, mtdna depletion can affect specific tissues (most commonly muscle or liver) or multiple organs, including the heart, brain, and kidneys. Since 2001, MDS has been linked to mutations in 8 nuclear genes. Mutations in TK2 1 (OMIM *188250) and RRM2B 2 (OMIM *604712) are associated with early-onset myopathy with or without renal proximal tubulopathy. Mutations in SUCLA1 3 (OMIM *611224) and SUCLA2 4 (OMIM *603921), encoding isoforms of succinyl coenzyme A lyase (a Krebscycle enzyme), have been associated with encephalomyopathy, while mutations in Twinkle (OMIM *60675), POLG (OMIM *174763), DGUOK (OMIM *601465), and MPV cause combined encephalopathy and liver failure. A variant form of hepatoneural MDS affects the Navajo population (Navajo neurohepatopathy) and has been associated with a mutation in MPV17. 11,12 Herein, we describe the clinical, molecular morphological, and biochemical features of 3 children (from 2 unrelated families) with hepatocerebral MDS secondary to novel MPV17 mutations. METHODS Routine muscle and liver biopsy specimen histologic examinations were performed as previously described. 13,14 Respiratory chain activities were also measured as previously 1108
2 a A a B I: Integral P: Position NAA I: 2.30 P: 2.04 Cho I: 2.30 P: Cr I: 1.75 P: 3.06 b b 0.2 Cr2 I: P: 3.95 Lac I: 1.73 P: Figure 1. Brain magnetic resonance imaging and magnetic resonance spectroscopy in patient 1. A, Diffusion-weighted images obtained at the horizontal level of the striatum (a and a ) and at the level of the centrum semiovale (b and b ). Reduced proton diffusion signals are observable in the left caudate nucleus and in the subcortical white matter. B, Magnetic resonance proton spectroscopic results obtained using a repetition time of 1500 milliseconds and an echo time of 135 milliseconds in the subcortical white matter. Notice the prominent inverted lactate peak (Lac). Insets show the brain region. 1 ppm described. 15 Genomic DNA from patients tissues was extracted using standard protocols. Real-time quantitative polymerase chain reaction (PCR) was used to evaluate mtdna content in liver and muscle biopsy specimens. For MPV17 sequence analysis, 7 coding exons and the exon-intron boundaries of the gene were amplified and sequenced directly as previously described. 9 Primers used for the long PCR that expands the region of exon 7 and downstream of exon 8 were 5 - GCCAACTTCTACCTGGTCCCCCTT-3 and 5 -GATCAC- GAGGTCAGTAGTTTGAA-3. The sequence variants found in the patients were evaluated in available relatives, as well as in 100 consecutive control subjects (200 alleles). REPORT OF CASES CASE 1 The third child of consanguineous Iraqi parents was born at 41 weeks after an uncomplicated pregnancy. Her birth weight was 3770 g, and the Apgar scores were 9, 10, and 10. Family history was positive for 2 miscarriages. The infant was hospitalized twice during the first 2 months of life for dehydration and diarrhea without hypoglycemia. At 2 months, she developed jaundice, and her liver was enlarged to 4 cm below the right costal margin. She was small for her age (weight and length were in the 10th percentiles) and microcephalic. She had a broad nasal bridge but no other dysmorphic features. Relevant laboratory findings included the following: signs of coagulopathy (quick time, 40%), increased serum concentration of fetoprotein ( ng/ml) (to convert -fetoprotein concentration to micrograms per liter, multiply by 1.0), markedly impaired absorption of fat-soluble vitamins (vitamin A level, 8 µg/dl) (to convert vitamin A level to micromoles per liter, multiply by ), hyperbilirubinemia (total bilirubin level, 8.4 mg/dl; and direct bilirubin level, 5.8 mg/dl) (to convert bilirubin levels to micromoles per liter, multiply by ), and high levels of aspartate aminotransferase (203 U/L; reference range, U/L) and alanine aminotransferase (91 U/L; reference range, 7-28 U/L) (to convert aspartate aminotransferase and alanine aminotransferase levels to microkatals per liter, multiply by ). Brain magnetic resonance (MR) imaging at 3 months of age was normal. An initial liver biopsy was performed at the same age. When she was readmitted at the age of 4 months, failure to thrive was evident, and her liver function had worsened. She developed hypoglycemia (glucose level, 22 mg/dl) (to convert glucose level to millimoles per liter, multiply by ) and lactic acidosis, with a lactate concentration of up to 54 mg/dl in plasma (reference range, mg/dl) and up to 72 mg/dl in cerebrospinal fluid (reference range, mg/dl) (to convert lactate concentration to millimoles per liter, multiply by 0.111). A second liver biopsy specimen at age 6 months showed progression of hepatic degeneration, and brain MR imaging revealed cytotoxic edema involving the subcortical white matter of both frontal lobes, more severe on the right (Figure 1). Magnetic resonance spectroscopy showed a slight but significantly elevated lactate peak within the parietooccipital white matter (Figure 2). Because of her severe and rapidly progressive liver disease and mild neurologic involvement, patient 1 was considered a candidate for liver transplantation. However, while on the transplant list, she developed severe metabolic crisis with hyperammonemia, lactic acidosis, and massive coagulation disorder. She also developed nephrolithiasis, and her neurologic status 1109
3 A B C D Figure 2. Liver morphologic findings in patient 1. A, Initial liver biopsy specimen showing disseminated hepatocellular cell necrosis, modest secondary portal inflammatory infiltration, and distinct portal fibrosis (hematoxylin-eosin [HE], original magnification 10). B, Liver biopsy specimen obtained months later shows increased fibrosis with progression to micronodular cirrhosis. Note the hepatocellular damage with acidophilic degeneration of disseminated cells and intrapseudolobular cholestasis (arrow) (HE, original magnification 50). C, Higher magnification shows microvesicular steatosis, acidophilic degeneration, and cell necrosis (HE, original magnification 100). D, Red staining of fibrous septa in liver cirrhosis (elastica van Gieson, original magnification 50). worsened, with the development of dystonic movement. She died at age 11 months of liver failure. CASE 2 This patient, the younger sister of patient 1, was born after an uneventful pregnancy and birth (weight, 3970 g; length, 56 cm; head circumference, 36 cm; and Apgar scores of 9, 10, and 10). Prenatal diagnosis had been offered to the parents but was refused. This child first showed clinical signs at 7 weeks of age, when she was first admitted because of severe failure to thrive, and at age 3 months she had severe dystrophy (3870 g). Her liver was palpable 4 cm below the costal margin. Apart from severe muscular hypotonia, no specific neurologic symptoms were found. Laboratory investigations revealed severe lactic acidosis ( 144 mg/dl in plasma) and cholestasis (total bilirubin level, 0.53 mg/dl; direct bilirubin level, 0.44 mg/dl; total bile acid level, 132 mg/dl [reference range, mg/dl] [to convert bile acid level to micromoles per liter, multiply by 2.448]; and lipoprotein X level, 98 mg/dl [reference range, 0-11 mg/dl] [to convert lipoprotein X level to micromoles per liter, multiply by ]), and her liver function was deteriorating (quick time, 23%; international normalized ratio, 2.7; aspartate aminotransferase level, 266 U/L [reference range, U/L]; alanine aminotransferase level, 148 U/L [reference range, U/L]; and glutamate dehydrogenase level, 110 U/L [reference range, 0-7 U/L]). Patient 2 died of liver failure at 5 months. CASE 3 This patient was born at full term (a 2.7-kg girl) by normal spontaneous vaginal delivery. She was the only child of unrelated parents, and conception was by artificial insemination with the father s sperm because of a history of endometriosis in the mother. The infant cried immediately after birth, but she was noted to feed poorly and to be shaky and jittery. She was discharged home at 2 days of life, but she was readmitted a few days later because of lethargy. Laboratory findings at that time revealed low glucose level, high plasma tyrosine and plasma lactate levels, and abnormal liver functions with coagulopathy. Brain MR imaging at 2 weeks showed bilateral subdural hemorrhages with an area of periventricular leukomalacia involving the right parietal region. Liver and skeletal muscle biopsy specimens were obtained. Because of low blood glucose levels, she underwent a fasting study at 2 months of age, which was stopped after 5.5 hours. Her lowest documented glucose level was 38 mg/dl. She was maintained on nasogastric feedings of an elemental formula every 3 hours, avoiding periods of overnight fasting. On physical examination at age 5 months, she appeared small for her age. She was hypotonic, with roving eye movements and nystagmus. She had severe failure to thrive and hepatomegaly (the liver edge was 5.5 cm below the right costal margin). A formal ophthalmologic examination showed nystagmus but normal fundus and optic discs. Her echocardiogram, electrocardiogram, renal function, and brainstem auditory- 1110
4 and visual-evoked responses were normal. Her condition worsened, and she died of liver failure at 9 months of age. Exon 2 Intron 2 C C T G A C A G C T N G T G A G T G T C C RESULTS In patient 1, histologic examination of an initial liver biopsy specimen obtained at 3 months of age revealed cholestasis, cell necrosis, mild microvesicular steatosis, and periportal fibrosis with inflammation (Figure 2A and C). These findings were much more marked at 6 months of age in a second biopsy specimen and had evolved to micronodular cirrhosis (Figure 2B and D). In patient 3, a liver biopsy specimen showed fibrosis, steatosis, cholestasis, hemosiderosis, glycogen storage, and hepatocellular swelling. Findings in a muscle biopsy specimen were normal. Oxidative enzyme stains and respiratory chain activities were normal in muscle, but activities of respiratory chain complexes containing mtdnaencoded subunits (complexes I and IV) were decreased in the liver. In patients 1 and 3, real-time PCR of liver tissue showed severe reduction in the ratios of mtdna to nuclear DNA. There was 70% depletion in patient 1 and 84% depletion in patient 3. Molecular genetic analysis showed 3 novel mutations in MPV17. Patients 1 and 2 had a homozygous G to A transition at nucleotide position 359 of exon 5. Their parents were heterozygous. The mutation changes the p.w120 into a TAG stop codon and is predicted to result in a truncated protein. Patient 3 was compound heterozygous. One allele (from the father) carried a missense mutation that changes a highly conserved G to T (p.g24w). The allele from the mother carried a 1.5-kb deletion that spanned from intron 7 well into exon 8 (Figure 3). All 3 mutations were absent in 100 healthy control subjects. COMMENT kb MW M F P Intron 7 Intron 8 A G G T G C C T G C C T G C A G C T T C C Figure 3. Molecular genetic analysis in patient 3. A, Electrophoretogram shows the heterozygous G to T change in exon 2. B, Polymerase chain reaction analysis from exon 7 to downstream of exon 8 revealed a 1.5-kilobase (kb) deletion, which covers exon 8 of MPV17. MW indicates molecular weight; M, mother; F, father; and P, patient. C, Sequencing analysis shows the point of this deletion. Mitochondrial DNA depletion syndrome differs from other mitochondrial disorders because it is a quantitative defect rather than a qualitative defect. The low copy number of mtdna in some tissues is likely to cause insufficient synthesis of respiratory chain components. Primary MDS is transmitted as an autosomal recessive trait and has been associated with mutations in 8 nuclear genes. Five of them (TK2, RRM2B, SUCLA1, SUCLA2, and DGUOK) 1-4,8 supply the mitochondria with nucleotide pools needed for DNA replication, and POLG and twinkle products function directly at the mtdna replication fork. 5-7 MPV17 encodes an inner membrane mitochondrial protein of unknown function. 9 The clinical spectrum of MDS is diverse. In some patients, only 1 organ is affected, while in others the syndrome is multisystemic. The liver seems particularly vulnerable to MPV17 mutations, as all described patients herein shared severe hepatopathy as a common clinical feature. As in our 3 cases, patients manifest hepatomegaly and progressive liver failure within the first weeks of life, leading to death a few months later. Initial symptoms include vomiting, diarrhea, failure to thrive, or developmental delay. Coagulopathy, hypoglycemia, lactic acidosis, elevated total and conjugated bilirubin levels, and high levels of serum alanine aminotransferase and aspartate aminotransferase are common. However, other organs are not spared, especially the brain. Most patients who initially showed isolated hepatopathy without clinical or neuroradiological signs of central nervous system involvement subsequently developed neurologic symptoms at a later stage of the disease; these included ataxia, tremor, dystonia, neuropathy, and altered ocular movement such as multidirectional nystagmus In patients 1 and 2 described herein, neurologic involvement also manifested in a second stage of the disease. Patient 1 developed dystonic movements associated with alterations seen on MR imaging and MR spectroscopy at age 7 months. In patient 2, the only neurologic sign at the age of 3 months was hypotonia, which may be of central origin but could be the result of severe muscle wasting. Patient 2 died of liver failure at 5 months. Patient 3 developed microcephaly, hypotonia, and nystagmus. Severe hepatic involvement in association with MDS has been described in patients carrying DGUOK or POLG1 mutations. Patients with POLG mutations typically have neurologic symptoms at the time of their first clinical ex- 1111
5 amination. In patients with features of Alpers- Huttenlocher syndrome on MR imaging, the most prominent symptom is intractable progressive epilepsy, while hepatopathy develops later in the course of the disease but may worsen rapidly, especially after exposure to valproic acid. However, we have also detected POLG mutations in children who were primarily admitted because of fulminant liver problems and minor neurologic problems in whom deterioration of cerebral functions occurred after liver transplantation. 16,17 In DGUOK deficiency, liver involvement seems to be the most prominent feature, leading to liver cirrhosis and causing earlyonset liver failure. MPV17 mutations associated with hepatic MDS were first described in Since then, 15 cases from 11 families have been ascribed to 7 different pathogenic MPV17 mutations Three were frameshift mutations, and 4 were missense mutations. We identified 3 additional MPV17 mutations. One was a nonsense mutation (the first described thus far to our knowledge) that resulted in a truncated protein abolishing the last 56 amino acids. The second was a missense mutation affecting a highly conserved amino acid in the first transmembrane domain of the protein. The third was a macrodeletion covering part of the seventh intron and the eighth exon of the gene. These data show that MPV17-related MDS is genetically heterogeneous, although the C 148 to G 149 dinucleotide of the MPV17 sequence has been postulated to be a mutational hot spot. 12 The treatment of acute liver failure and progressive liver disease in mitochondrial hepatopathies remains unsatisfactory. Present treatments involve the use of various vitamins, cofactors, and respiratory substrates, none of which have proven effective. Supportive treatments may include infusion of sodium bicarbonate for acute metabolic acidosis, intravenous administration of glucose, or nasogastric feedings to avoid fasting hypoglycemia. 18,19 Cornstarch administration can also protect against fasting hypoglycemia (Rossella Parini, MD; oral communication; May 2006). Liver transplantation is a treatment option for end-stage liver disease associated with MDS, but the role of liver transplantation in mitochondrial hepatopathy is controversial, largely because of the multisystemic nature of this disorder. The few available studies show mixed outcomes, with a survival rate of less than 50% The presence of extrahepatic clinical disease is an absolute contraindication to liver transplantation, but neurologic involvement may be unrecognized before transplantation and may become apparent only after the procedure. 24 Therefore, the absence of extrahepatic features of mitochondrial disease at the time of liver transplantation does not warrant a good outcome even if the transplant is successful. On the other hand, a few patients with isolated liver involvement have undergone successful liver transplantation. 25 Therefore, careful screening of potential organ recipients is crucial because systemic involvement portends poor long-term prognosis. Recently, MR imaging and MR spectroscopy have proven to be valuable tools in the evaluation of central nervous system involvement in candidates for transplant because of acute liver failure due to mitochondrial hepatopathy. 26 Our study reinforces the concept that MPV17 mutations are associated with rapidly progressive infantile hepatic failure and that neurologic involvement is a subsequent independent event. Accepted for Publication: March 5, Correspondence: Massimo Zeviani, MD, PhD, Unit of Molecular Neurogenetics, Pierfranco and Luisa Mariani Center for the Study of Children s Mitochondrial Disorders, C. Besta Neurological Institute Foundation, via Temolo 4, Milano 20126, Italy (zeviani@fastwebnet.it or Author Contributions: Dr Zeviani had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Spinazzola, Santer, Schaefer, Ding, and Zeviani. Acquisition of data: Spinazzola, Santer, Akman, Tsiakas, Ding, Karadimas, Shanske, Ganesh, and Di Mauro. Analysis and interpretation of data: Spinazzola, Santer, Akman, Schaefer, Di Mauro, and Zeviani. Drafting of the manuscript: Spinazzola, Shanske, and Ganesh. Critical revision of the manuscript for important intellectual content: Santer, Akman, Tsiakas, Schaefer, Karadimas, Di Mauro, and Zeviani. Obtained funding: Ding and Zeviani. Administrative, technical, and material support: Santer, Akman, Tsiakas, Schaefer, and Karadimas. Study supervision: Spinazzola, Shanske, Di Mauro, and Zeviani. Financial Disclosure: None reported. Funding/Support: This study was supported by Fondazione Pierfranco e Luisa Mariani and by grant GGP07019 from the European Union Framework Program (MITOCIRCLE and EUMITOCOMBAT). REFERENCES 1. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001; 29(3): Bourdon A, Minai L, Serre V, et al. Mutation of RRM2B, encoding p53- controlled ribonucleotide reductase (p53r2), causes severe mitochondrial DNA depletion. Nat Genet. 2007;39(6): Ostergaard E, Christensen E, Kristensen E, et al. Deficiency of the subunit of succinate coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet. 2007;81(2): Elpeleg O, Miller C, Hershkovitz E, et al. Deficiency of the ADP-forming succinyl CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet. 2005;76(6): Sarzi E, Goffart S, Serre V, et al. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol. 2007;62(6): Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lönnqvist T. Recessive twinkle mutations in early onset encephalopathy with mtdna depletion. Brain. 2007;130(pt 11): Naviaux RK, Nguyen KV. POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann Neurol. 2004;55(5): Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001; 29(3): Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion [letter]. Nat Genet. 2006;38(5): Wong LJ, Brunetti-Pierri N, Zhang Q, et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology. 2007; 46(4): Karadimas CL, Vu TH, Holve SA, et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet. 2006;79(3): Spinazzola A, Massa V, Hirano M, Zeviani M. Lack of founder effect for an iden- 1112
6 tical mtdna depletion syndrome (MDS) associated MPV17 mutation shared by Navajos and Italians. Neuromuscul Disord. 2008;18(4): Tanji K, Bonilla E. Optical imaging techniques (histochemical, immunohistochemical and in situ hybridization staining methods) to visualize mitochondria. Methods Cell Biol. 2001;65: Bioulac-Sage P, Parrot-Roulaud F, Mazat JP, et al. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liver. Hepatology. 1993;18(4): Bugiani M, Invernizzi F, Alberio S. Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta. 2004;1659(2-3): Simonati A, Filosto M, Tomelleri G, et al. Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease. J Neurol. 2003;250(6): Ferrari G, Lamatea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gamma A. Brain. 2005;128(pt 4): Sokol RJ, Treem WR. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr. 1999;28(1): Gillis LA, Sokol RJ. Gastrointestinal manifestations of mitochondrial disease. Gastroenterol Clin North Am. 2003;32(3): Sokal EM, Sokol R, Cormier V, et al. Liver transplantation in mitochondrial respiratory chain disorders. Eur J Pediatr. 1999;158(suppl 2):S81-S Dubern B, Broue P, Dubinsson C, et al. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation. 2001;71: Delarue A, Paut O, Guys JM, et al. Inappropriate liver transplantation in a child with Alper-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant. 2000;4(1): Rabinowitz SS, Gelfond D, Chen CK, et al. Hepatocerebral mitochondrial DNA depletion syndrome: clinical and morphological features of a nuclear gene mutation. J Pediatr Gastroenterol Nutr. 2004;38(2): Thomson M, McKieman P, Buckles J, Mayer D, Kelly D. Generalized mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr. 1998;26(4): Dubern B, Broue P, Dubinsson C, et al. Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation. 2001;71(5): Haas R, Dietrich R. Neuroimaging of mitochondrial disorders. Mitochondrion. 2004;4(5-6): Announcement Trial Registration Required. In concert with the International Committee of Medical Journal Editors (ICMJE), Archives of Neurology will require, as a condition of consideration for publication, registration of all trials in a public trials registry (such as Trials must be registered at or before the onset of patient enrollment. This policy applies to any clinical trial starting enrollment after July 1, For trials that began enrollment before this date, registration will be required by September 13, 2005, before considering the trial for publication. The trial registration number should be supplied at the time of submission. For details about this new policy, and for information on how the ICMJE defines a clinical trial, see the editorial by DeAngelis et al in the January issue of Archives of Dermatology (2005;141:76-77). Also see the Instructions to Authors on our Web site:
variant led to a premature stop codon p.k316* which resulted in nonsense-mediated mrna decay. Although the exact function of the C19L1 is still
157 Neurological disorders primarily affect and impair the functioning of the brain and/or neurological system. Structural, electrical or metabolic abnormalities in the brain or neurological system can
More informationPresentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
More informationCLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands
CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE Bwee Tien Poll-The Amsterdam UMC The Netherlands FRAMEWORK OF PRINCIPALS 1. Problem-oriented clinical approach 2. Biomarkers in plasma, urine, CSF
More informationMetabolic diseases of the liver
Metabolic diseases of the liver Central role in metabolism Causes and mechanisms of dysfunction Clinical patterns of metabolic disease Clinical approach to problem-solving Specific disorders Liver s central
More informationTHIAMINE TRANSPORTER TYPE 2 DEFICIENCY
THIAMINE TRANSPORTER TYPE 2 DEFICIENCY WHAT IS THE THIAMINE TRANSPORTER TYPE 2 DEFICIENCY (hthtr2)? The thiamine transporter type 2 deficiency (hthtr2) is a inborn error of thiamine metabolism caused by
More informationMetabolic Disorders. Chapter Thomson - Wadsworth
Metabolic Disorders Chapter 28 1 Metabolic Disorders Inborn errors of metabolism group of diseases that affect a wide variety of metabolic processes; defective processing or transport of amino acids, fatty
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationNovel c.191c>g (p.pro64arg) MPV17 mutation identified in two pairs of unrelated Polish siblings with mitochondrial hepatoencephalopathy
Clin Genet 2014: 85: 573 577 Printed in Singapore. All rights reserved Short Report 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12228 Novel c.191c>g
More informationReferring Physician Information Name: (Last, First, Middle):
Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationMuscle Metabolism. Dr. Nabil Bashir
Muscle Metabolism Dr. Nabil Bashir Learning objectives Understand how skeletal muscles derive energy at rest, moderate exercise, and strong exercise. Recognize the difference between aerobic and anaerobic
More informationChildhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings, mtdna mutations and outcome in six children
Lu and Huang Italian Journal of Pediatrics 2013, 39:60 ITALIAN JOURNAL OF PEDIATRICS CASE REPORT Open Access Childhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings,
More informationBasic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH
Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,
More informationNatural history of α-1-atd in children
Natural history of α-1-atd in children Agnieszka Bakuła Dpt of Gastroenterology, Hepatology, Nutrition Disorders and Paediatrics The Children s Memorial Health Institute Warsaw, Poland Topics to be discussed
More informationPediatric Neurology. Alpers-Huttenlocher Syndrome
Pediatric Neurology 48 (2013) 167e178 Contents lists available at ScienceDirect Pediatric Neurology journal homepage: www.elsevier.com/locate/pnu Review Article Alpers-Huttenlocher Syndrome Russell P.
More informationThe spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital
The spectrum and outcome of the neonates with inborn errors of metabolism at a tertiary care hospital Dr. Sevim Ünal Neonatology Division, Ankara Children s Hematology Oncology Research Hospital, Ankara,
More informationREQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First
#: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST
More informationGlycogen Storage Disease
Glycogen Storage Disease 1 Introduction The food we eat is usually used for growth, tissue repair and energy. The body stores what it does not use. Excess sugar, or glucose, is stored as glycogen in the
More informationA CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL
A CASE OF GIANT AXONAL NEUROPATHY HEMANANTH T SECOND YEAR POST GRADUATE IN PAEDIATRICS INSTITUTE OF SOCIAL PAEDIATRICS GOVERNMENT STANLEY HOSPITAL CASE HISTORY Nine year old male child Second born Born
More informationAdvances in genetic diagnosis of neurological disorders
Acta Neurol Scand 2014: 129 (Suppl. 198): 20 25 DOI: 10.1111/ane.12232 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ACTA NEUROLOGICA SCANDINAVICA Review Article Advances in genetic diagnosis
More informationThe Organism as a system
The Organism as a system PATIENT 1: Seven-year old female with a history of normal development until age two. At this point she developed episodic vomiting, acidosis, epilepsy, general weakness, ataxia
More informationBile acid abnormalities in peroxisomal disorders
Bile acid abnormalities in peroxisomal disorders Sacha Ferdinandusse Lab. Genetic Metabolic Diseases Academic Medical Center Amsterdam Peroxisomes play an important role in bile acid biosynthesis Bile
More informationNutritional Interventions in Primary Mitochondrial Disorders
Nutritional Interventions in Primary Mitochondrial Disorders Carolyn J Ellaway MBBS PhD FRACP CGHGSA Genetic Metabolic Disorders Service Sydney Children s Hospital Network Disciplines of Child and Adolescent
More informationMutations. A2 Biology For WJEC
12. Mutation is a change in the amount, arrangement or structure in the DNA of an organism. 13. There are two types of mutations, chromosome mutations and gene mutations. Mutations A2 Biology For WJEC
More informationMuscular Dystrophy. Biol 405 Molecular Medicine
Muscular Dystrophy Biol 405 Molecular Medicine Duchenne muscular dystrophy Duchenne muscular dystrophy is a neuromuscular disease that occurs in ~ 1/3,500 male births. The disease causes developmental
More informationClinical Spectrum and Genetic Mechanism of GLUT1-DS. Yasushi ITO (Tokyo Women s Medical University, Japan)
Clinical Spectrum and Genetic Mechanism of GLUT1-DS Yasushi ITO (Tokyo Women s Medical University, Japan) Glucose transporter type 1 (GLUT1) deficiency syndrome Mutation in the SLC2A1 / GLUT1 gene Deficiency
More informationDhanpat Jain Yale University School of Medicine, New Haven, CT
Dhanpat Jain Yale University School of Medicine, New Haven, CT Case history 15 years old female presented with fatigue. Found to have features suggestive of cirrhosis with esophageal varices, splenomegaly
More informationCorporate Medical Policy
Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018
More informationCryptogenic Cirrhosis: An Approach To The Diagnosis In The Era Of Molecular and Genomic Medicine
Cryptogenic Cirrhosis: An Approach To The Diagnosis In The Era Of Molecular and Genomic Medicine Introduction and historical perspective: Cryptogenic cirrhosis(cc) is defined as cases of cirrhosis where
More informationIntroduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.
Introduction to Organic Acidemias Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.2014 A Brief Historical Overview Garrod, Archibald E. 1902. The Incidence of
More informationMYOCLONIC EPILEPSY WITH RAGGED RED FIBERS (MERRF) By- Promie Faruque
MYOCLONIC EPILEPSY WITH RAGGED RED FIBERS (MERRF) By- Promie Faruque PHYSIOLOGY -MERRF is a rare panethnic mitochondrial disease which is caused by mutations in the mtdna -It mainly affects the muscle
More informationThe breakdown of fats to provide energy occurs in segregated membrane-bound compartments
CPT1a deficiency The breakdown of fats to provide energy occurs in segregated membrane-bound compartments of the cell known as mitochondria. Carnitine palmitoyltransferase Ia (CPT1a) is a protein that
More informationSummary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism
Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to
More informationSystematizing in vivo modeling of pediatric disorders
Systematizing in vivo modeling of pediatric disorders Nicholas Katsanis, Ph.D. Duke University Medical Center Center for Human Disease Modeling Rescindo Therapeutics www.dukegenes.org Task Force for
More informationNIH Public Access Author Manuscript Kidney Int. Author manuscript; available in PMC 2011 September 1.
NIH Public Access Author Manuscript Published in final edited form as: Kidney Int. 2011 March ; 79(6): 691 692. doi:10.1038/ki.2010.514. The case: Familial occurrence of retinitis pigmentosa, deafness
More informationPathophysiology. Tutorial 1 Genetic Diseases
Pathophysiology Tutorial 1 Genetic Diseases ILOs Analyze genetic pedigrees and recognize the mode of inheritance of diseases. Differentiate between patterns of inheritance based on the type of the protein
More informationSCAD and GA-II: Truths and Confusions
SCAD and GA-II: Truths and Confusions Bill Rhead* Medical College of Wisconsin *MD, PhD GA-II Severe GA-II is as bad as: SCAD + MCAD + COMBINED! VLCAD + IVA + GA-I Severe GA-II is always fatal Mild
More informationGlycogen Storage Disease Type III also known as Cori or Forbe s Disease/Debrancher Enzyme Deficiency
Glycogen Storage Disease Type III also known as Cori or Forbe s Disease/Debrancher Enzyme Deficiency What is GSDIII? Glycogen Storage Disease type 3 is an inherited condition caused by a defect in a gene
More informationSalicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes
Salicylate (Aspirin) Ingestion California Poison Control 1-800-876-4766 Background 1. The prevalence of aspirin-containing analgesic products makes these agents, found in virtually every household, common
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationInborn errors of metabolism
ESPEN Congress Nice 2010 From child to adult nutrition Inborn errors of metabolism Pascal Crenn Inborn errors of metabolism: from child to adult Pascal Crenn Hôpital Raymond Poincaré 92380 Garches. France
More informationNuclear-Mitochondrial Intergenomic Communication Disorders
Chapter 13 Nuclear-Mitochondrial Intergenomic Communication Disorders Ligia S. Almeidao, Celia Nogueirao and Laura Vilarinho Additional information is available at the end of the chapter http://dx.doi.org/10.5772/47819
More informationExome sequencing identifies ACAD9 mutations as a cause of complex I deficiency
Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency Tobias B. Haack 1,2,11, Katharina Danhauser 2,1,11, Birgit Haberberger 2,1, Jonathan Hoser 3, Valentina Strecker 4, Detlef
More informationCystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst?
Bahrain Medical Bulletin, Vol. 36, No. 2, June 2014 Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst? Hussein Ahmed Mohammed Hamdy, MRCSEd, FEBPS* Hind Mustafa
More informationPancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis
Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis Naoki Tanaka 1, Akira Horiuchi 2, Takahide Yokoyama 3, Shigeyuki Kawa 1, and Kendo Kiyosawa 1 1 Department of Gastroenterology,
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name OMIM number for disease Disease alternative names please provide any alternative
More informationA Deficit of ATP-ase Subunit 8: with Contribution for Two New Cases
A Deficit of ATP-ase Subunit 8: with Contribution for Two New Cases Stancheva M. 1*, Radeva B. 2, Naumova E. 3, Mihailova S. 3 1 University Children s Hospital Alexandrovska, Sofia, Bulgaria 2 University
More informationJULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology
JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Maradin, M., Fumić, K., Hansikova, H., Tesarova, M., Wenchich, L., Dorner, S., Sarnavka, V., Zeman, J., Barić, I. (2006) Fumaric aciduria: Mild phenotype in a 8-year-old
More informationPediatrics. Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment. Definition. Epidemiology of Pyruvate Kinase Deficiency.
Pediatrics Pyruvate Kinase Deficiency (PKD) Symptoms and Treatment See online here Pyruvate kinase deficiency is an inherited metabolic disorder characterized by a deficiency in the enzyme "pyruvate kinase"
More informationNeurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018
Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive
More informationRecent Advances in Neurology 2014: Neuromuscular Case Presentations
Recent Advances in Neurology 2014: Neuromuscular Case Presentations Jeffrey W. Ralph, MD Associate Clinical Professor Patient #1: Young woman with severe polyneuropathy 25 year-old woman Normal motor and
More informationSELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)
DEFICIENCY OF METABOLITE -HYPOXIA AND HYPOGLYCEMIA -HYPOVITAMINOSIS SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA) -SPECIFIC CELL TYPE NEURONS>OLIGODENDROCYTES>ASTROCYTES -SPECIFIC BRAIN REGION PYRAMIDAL
More informationGaucher disease 3/22/2009. Mendelian pedigree patterns. Autosomal-dominant inheritance
Mendelian pedigree patterns Autosomal-dominant inheritance Autosomal dominant Autosomal recessive X-linked dominant X-linked recessive Y-linked Examples of AD inheritance Autosomal-recessive inheritance
More informationTraining Syllabus CLINICAL SYLLABUS
Training Syllabus CLINICAL SYLLABUS SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE Updated July 2006 This syllabus is intended as a guide. Whilst the training should be comprehensive,
More informationLiver failure &portal hypertension
Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and
More informationTitle: Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults
Title: Alagille syndrome: an uncommon cause of intrahepatic cholestasis in adults Authors: Wei Zhang, Xinyan Zhao, Jian Huang, Xiaojuan Ou, Jidong Jia DOI: 10.17235/reed.2019.5679/2018 Link: PubMed (Epub
More informationMetabolic Precautions & ER Recommendations
Metabolic Precautions & ER Recommendations * To whom correspondence Sumit Parikh, should MD be addressed Center for Pediatric Neurology Cleveland Clinic Cleveland, OH UMDF 2010 The catabolic state Entering
More informationNeonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP
The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy
More informationLong Term Follow-Up Clinical Guidelines for X-linked Adrenoleukodystrophy
Long Term Follow-Up Clinical Guidelines for X-linked Adrenoleukodystrophy Gerald Raymond, M.D. Department of Pediatrics and Neurology Penn State Medical Center Hershey, PA June 20, 2018 Disclosure Information
More informationProtein & Enzyme Lab (BBT 314)
Protein & Enzyme Lab (BBT 314) Experiment 3 A: Determination of the enzyme ALT or SGPT activity in serum by enzymatic method using Bioanalyzer Background: Alanine aminotransferase (glutamate pyruvate transaminase)
More informationDisclosures Drug-induced Acute Liver Failure
Disclosures Drug-induced Acute Liver Failure I have nothing to disclose. Raga Ramachandran, MD, PhD UCSF Pathology May 25, 2012 Acute liver failure (Fulminant hepatitis) Definition - onset of hepatic encephalopathy
More informationNew developments in Urea Cycle Disorders and its impact on patients
New developments in Urea Cycle Disorders and its impact on patients Johannes Häberle University Children s Hospital Zurich, Division of Metabolism 16 June 2015 SFEIM 2015, Lille, France The urea cycle
More information- Aya Alomoush. - Talal Al-Zabin. - Belal Azab. 1 P a g e
24 - Aya Alomoush - Talal Al-Zabin - Belal Azab 1 P a g e 1) Features of autosomal dominant inheritance: A) Vertical transmission: direct transmission from grandparent to parent to child without skipping
More informationImportant Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)
Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil
More informationExploding Genetic Knowledge in Developmental Disabilities. Disclosures. The Genetic Principle
Exploding Genetic Knowledge in Developmental Disabilities How to acquire the data and how to make use of it Elliott H. Sherr MD PhD Professor of Neurology & Pediatrics UCSF Disclosures InVitae: clinical
More informationAddress: MRC National Institute for Medical Research The Ridgeway Mill Hill London NW7 1AA UK
CURRICULUM VITAE Name: Antonella Spinazzola Nationality: Italian Address: MRC National Institute for Medical Research The Ridgeway Mill Hill London NW7 1AA UK Phone 020 88162273 e-mail: aspinaz@nimr.mrc.ac.uk
More informationDisorders of Carbohydrates. Disorders of Galactose Metabolism Glycogen Storage Diseases Diabetes Mellitus
Disorders of Carbohydrates Metabolism Disorders of Galactose Metabolism Glycogen Storage Diseases Diabetes Mellitus Disorders of Galactose Metabolism GALACTOSE Galactose is a sugar that is found mainly
More informationHuman Genetic Diseases (non mutation)
mutation) Pedigrees mutation) 1. Autosomal recessive inheritance: this is the inheritance of a disease through a recessive allele. In order for the person to have the condition they would have to be homozygous
More informationUSCAP PEDIATRIC PATHOLOGY Slide Session
USCAP PEDIATRIC PATHOLOGY Slide Session CASE 4 Milton J. Finegold Patient 1 Slide B Twin A: 27 4/7 wk gestation; 1090 gm Maternal gestational DM, ITP - Rx IVIG Ventilatory support for 3 months Multiple
More informationWhat s New in Newborn Screening?
What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is administered by the Illinois Department of Public Health.
More informationBiliary Atresia. Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s
Biliary Atresia Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s Biliary Atresia Incidence: 1/8,000-15,000 live births Girls > boys 1.5:1 The most common cause
More informationLong-Term Outcomes After Liver Transplantation for Deoxyguanosine Kinase Deficiency: A Single-Center Experience and a Review of the Literature
LIVER TRANSPLANTATION 20:464 472, 2014 ORIGINAL ARTICLE Long-Term Outcomes After Liver Transplantation for Deoxyguanosine Kinase Deficiency: A Single-Center Experience and a Review of the Literature Enke
More informationCryptogenic Cirrhosis: An Approach To The Diagnosis In The Era Of Molecular Medicine
Cryptogenic Cirrhosis: An Approach To The Diagnosis In The Era Of Molecular Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control
More informationCase report Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy
Case report Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy Abdelmoneim EM Kheir (1), Wisal MA Ahmed (2), Israa Gaber (2), Sara MA Gafer (2), Badreldin M Yousif
More informationModule : Clinical correlates of disorders of metabolism Block 3, Week 2
Module : Clinical correlates of disorders of metabolism Block 3, Week 2 Department of Paediatrics and Child Health University of Pretoria Tutor : Prof DF Wittenberg : dwittenb@medic.up.ac.za Aim of this
More informationPARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN
PARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN Praveen Goday MBBS CNSC Associate Professor Pediatric Gastroenterology Medical College of Wisconsin Milwaukee, WI Parenteral Nutrition-Associated
More informationMITOCHONDRIAL DISEASE. Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital
MITOCHONDRIAL DISEASE Amel Karaa, MD Mitochondrial Disease Program Massachusetts General Hospital Disclosures & Disclaimers United Mitochondrial Disease Foundation Research Grant North American Mitochondrial
More informationClinical Cell Biology Organelles in Health and Disease
Department of Ophthalmology University of Kiel, University Medical Center Director: Prof. Dr. Johann Roider Clinical Cell Biology Organelles in Health and Disease Prof. Dr. Alexa Klettner Clinical cell
More informationIn the past 13 years, a new chapter of human genetics, mitochondrial genetics, has opened
ARTICLE The Other Human Genome Alan L. Shanske, MD; Sara Shanske, PhD; Salvatore DiMauro, MD In the past 13 years, a new chapter of human genetics, mitochondrial genetics, has opened up and is becoming
More informationDistal renal tubular acidosis: genetic and clinical spectrum
Distal renal tubular acidosis: genetic and clinical spectrum Sabrina Giglio Medical Genetics Unit, Meyer Children s University Hospital, University of Florence sabrina.giglio@meyer.it sabrinarita.giglio@unifi.it
More informationA study of 133 Chinese children with mitochondrial respiratory chain complex I deficiency
Clin Genet 2015: 87: 179 184 Printed in Singapore. All rights reserved Short Report 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLNCAL GENETCS doi: 10.1111/cge.12356 A study of 133 Chinese
More informationProteins. Length of protein varies from thousands of amino acids to only a few insulin only 51 amino acids
Proteins Protein carbon, hydrogen, oxygen, nitrogen and often sulphur Length of protein varies from thousands of amino acids to only a few insulin only 51 amino acids During protein synthesis, amino acids
More informationApproach to the Genetic Diagnosis of Neurological Disorders
Approach to the Genetic Diagnosis of Neurological Disorders Dr Wendy Jones MBBS MRCP Great Ormond Street Hospital for Children National Hospital for Neurology and Neurosurgery What is a genetic diagnosis?
More informationHuman inherited diseases
Human inherited diseases A genetic disorder that is caused by abnormality in an individual's DNA. Abnormalities can range from small mutation in a single gene to the addition or subtraction of a whole
More informationA Lawyer s Perspective on Genetic Screening Performed by Cryobanks
A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child
More informationOxidation of Long Chain Fatty Acids
Oxidation of Long Chain Fatty Acids Dr NC Bird Oxidation of long chain fatty acids is the primary source of energy supply in man and animals. Hibernating animals utilise fat stores to maintain body heat,
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Leber congenital amaurosis OMIM number for disease 204000 Disease alternative
More informationNeonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012
Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012 Hypotonia: reduced tension or resistance to range of motion Localization can be central (brain), peripheral (spinal cord, nerve,
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Alpha-1 Antitrypsin Deficiency File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alpha_1_antitrypsin_deficiency 5/2012
More informationBiochemistry #02. The biochemical basis of skeletal muscle and bone disorders Dr. Nabil Bashir Bara Sami. 0 P a g e
]Type text[ ]Type text[ ]Type text[ Biochemistry #02 The biochemical basis of skeletal muscle and bone disorders Dr. Nabil Bashir Bara Sami 0 P a g e Greetings everyone, ladies and gentlemen The biochemical
More informationSEX-LINKED INHERITANCE. Dr Rasime Kalkan
SEX-LINKED INHERITANCE Dr Rasime Kalkan Human Karyotype Picture of Human Chromosomes 22 Autosomes and 2 Sex Chromosomes Autosomal vs. Sex-Linked Traits can be either: Autosomal: traits (genes) are located
More informationFatty Acid Beta-Oxidation Disorders: A Brief Review
Mini Review Received: July 12, 2015 Accepted: November 12, 2015 Published online: March 11, 2016 Fatty Acid Beta-Oxidation Disorders: A Brief Review Vijay A. Vishwanath Division of Pediatric Neurology,
More informationThe citric acid cycle Sitruunahappokierto Citronsyracykeln
The citric acid cycle Sitruunahappokierto Citronsyracykeln Ove Eriksson BLL/Biokemia ove.eriksson@helsinki.fi Metabolome: The complete set of small-molecule metabolites to be found in a cell or an organism.
More informationIdentification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome
Identification of a novel duplication mutation in the VHL gene in a large Chinese family with Von Hippel-Lindau (VHL) syndrome L.H. Cao 1, B.H. Kuang 2, C. Chen 1, C. Hu 2, Z. Sun 1, H. Chen 2, S.S. Wang
More informationNot Your Typical Case of Ketotic Hypoglycemia
Not Your Typical Case of Ketotic Hypoglycemia Linda Steinkrauss, RN, MSN, CPNP Objectives By the end of this session, attendees should be able to: 1. Discuss the difference between idiopathic ketotic hypoglycemia
More informationSupplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our
1 2 Supplemental Data: Detailed Characteristics of Patients with MKRN3 Mutations 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Patient 1 was born after an uneventful pregnancy. She presented
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More informationAssociation of motor milestones and SMN2 copy and outcome in spinal muscular. atrophy types 0 4
jnnp-2016-314292 1 - SUPPLEMENTARY FILE - Methods and additional data on clinical characteristics and motor development Association of motor milestones and SMN2 copy and outcome in spinal muscular atrophy
More informationMethylmalonic aciduria
Methylmalonic aciduria Introductory information Written by: F. Hörster, S. Kölker & P. Burgard Reviewed & Revised for North America by: S. van Calcar Methylmalonic aciduria MMA 2 Methylmalonic aciduria
More information